- Home
- ANTE vs SNGX Comparison
ANTE vs SNGX Comparison
Compare ANTE & SNGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANTE
- SNGX
- Stock Information
- Founded
- ANTE 2005
- SNGX 1987
- Country
- ANTE China
- SNGX United States
- Employees
- ANTE N/A
- SNGX N/A
- Industry
- ANTE Advertising
- SNGX Biotechnology: Pharmaceutical Preparations
- Sector
- ANTE Consumer Discretionary
- SNGX Health Care
- Exchange
- ANTE Nasdaq
- SNGX Nasdaq
- Market Cap
- ANTE 6.2M
- SNGX 6.1M
- IPO Year
- ANTE N/A
- SNGX 1987
- Fundamental
- Price
- ANTE $0.43
- SNGX $2.10
- Analyst Decision
- ANTE
- SNGX
- Analyst Count
- ANTE 0
- SNGX 0
- Target Price
- ANTE N/A
- SNGX N/A
- AVG Volume (30 Days)
- ANTE 7.1M
- SNGX 29.1K
- Earning Date
- ANTE 05-16-2025
- SNGX 05-09-2025
- Dividend Yield
- ANTE N/A
- SNGX N/A
- EPS Growth
- ANTE N/A
- SNGX N/A
- EPS
- ANTE 2.64
- SNGX N/A
- Revenue
- ANTE $500,000.00
- SNGX $119,371.00
- Revenue This Year
- ANTE N/A
- SNGX N/A
- Revenue Next Year
- ANTE N/A
- SNGX N/A
- P/E Ratio
- ANTE $0.16
- SNGX N/A
- Revenue Growth
- ANTE N/A
- SNGX N/A
- 52 Week Low
- ANTE $0.26
- SNGX $1.83
- 52 Week High
- ANTE $2.90
- SNGX $14.88
- Technical
- Relative Strength Index (RSI)
- ANTE 45.32
- SNGX 42.28
- Support Level
- ANTE $0.38
- SNGX $2.25
- Resistance Level
- ANTE $0.50
- SNGX $2.28
- Average True Range (ATR)
- ANTE 0.16
- SNGX 0.11
- MACD
- ANTE -0.02
- SNGX -0.01
- Stochastic Oscillator
- ANTE 1.44
- SNGX 35.48
About ANTE AirNet Technology Inc.
AirNet Technology Inc provides in-flight solutions to connectivity, entertainment, and digital multimedia in China. It offers Internet connections through a network of satellites and land-based beacons, provides airline travelers with interactive entertainment, and breaking news, and furnishes corporate clients with advertisements tailored to the perceptions of the travelers. The revenues are mainly derived from selling advertising time slots on the companies advertising networks and cryptocurrency mining.
About SNGX Soligenix Inc.
Soligenix Inc is a late-stage biopharmaceutical company based in the United States. It focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need. The company operates through two business segments namely Specialized BioTherapeutics and Public Health Solutions. It generates maximum revenue from Public Health Solutions with active development programs for RiVax, its ricin toxin vaccine candidate, SGX943, its therapeutic candidate for antibiotic resistant and emerging infectious disease, and its research programs to identify and develop novel vaccine candidates targeting viral infection including Ebola, Marburg and SARS-CoV-2 (the cause of COVID-19).